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osteoblast differentiation
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1

Notch signaling critically controls cell fate decisions in mammals, both during embryogenesis and in adults. In the
skeleton, Notch suppresses osteoblast differentiation and sustains bone marrow mesenchymal progenitors during
postnatal life. Stabilizing mutations of Notch2 cause Hajdu-Cheney syndrome, which is characterized by early-onset
osteoporosis in humans, but the mechanism whereby Notch inhibits bone accretion is not fully understood. Here,
we report that activation of Notch signaling by either Jagged1 or the Notch2 intracellular domain suppresses glucose
metabolism and osteoblast differentiation in primary cultures of bone marrow mesenchymal progenitors. Importantly,
deletion of Notch2 in the limb mesenchyme increases both glycolysis and bone formation in the long bones of postnatal
mice, whereas pharmacological reduction of glycolysis abrogates excessive bone formation. Mechanistically, Notch reduces
the expression of glycolytic and mitochondrial complex I genes, resulting in a decrease in mitochondrial respiration,
superoxide production, and AMPK activity. Forced activation of AMPK restores glycolysis in the face of Notch signaling.
Thus, suppression of glucose metabolism contributes to the mechanism, whereby Notch restricts osteoblastogenesis from
bone marrow mesenchymal progenitors.

Introduction

Notch signaling between neighboring cells critically controls cell
fate decisions in all metazoans (1, 2). In mammalian cells, engagement of the Notch receptors (Notch1–4) by the ligands (Jagged1
and -2 and Delta-like 1, -3, and -4) triggers sequential proteolysis
of the receptors, which culminates in intramembranous cleavages
by the γ-secretase complex and results in release of the Notch
intracellular domain (NICD) (3–5). In the best-studied “canonical” mechanism, NICD released from the plasma membrane
translocates to the nucleus, where it interacts with the transcription factor RBPjk and a mastermind-like transcriptional coactivator (Maml1–3) to activate the transcription of target genes (6).
Among the best known targets of Notch signaling are the Hes/
Hey family of basic helix-loop-helix (bHLH) transcription repressors (7). However, the regulation of individual Hes/Hey proteins
by Notch and their role in mediating Notch function are highly
dependent on cell context.
Mouse genetic studies have uncovered important functions
for Notch signaling in bone. Genetic deletion of either the γ-secretase catalytic subunits presenilin 1 and -2, or Notch1 and -2 in the
embryonic limb mesenchyme results in excessive osteoblast differentiation at the expense of bone marrow mesenchymal progenitors (8). More recently, specific deletion of Notch2 in early-stage
osteoblast lineage cells with Runx2-Cre increased trabecular bone
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mass in a site-specific manner (9). In addition, Jagged1 appears to
be a major ligand in the maintenance of the osteoprogenitor pool
(10). Consistent with the negative role of Notch in osteoblast differentiation, forced expression of NICD in osteoblastic precursors
reduced osteoblast numbers and caused osteopenia (11). Intriguingly, forced expression of NICD at a later stage of the osteoblast
lineage led to sclerosis owing to excessive proliferation of the
immature osteoblasts, highlighting stage-specific functions of
constitutive Notch activation in the osteoblast lineage (12). Abnormal Notch activation in mesenchymal progenitors has also been
implicated in decreased osteoblast differentiation associated
with rheumatoid arthritis (13). In keeping with the mouse studies,
Notch1 haploinsufficiency in humans causes ectopic osteoblast
differentiation and calcification in the aortic valves (14, 15), whereas Notch2 stabilizing mutations are responsible for Hadju-Cheney
syndrome (HCS), a disorder of severe and progressive bone loss
(16, 17). Mice carrying an HCS mutation knockin allele through
the germ line developed severe osteopenia due to increased bone
resorption (18). More recently, a mouse strain expressing a conditional Notch2-knockin allele lacking the PEST degradation signal
was created, and activation of the allele specifically in osteoblasts
resulted in osteopenia due to increased Rankl expression, which
promotes osteoclastogenesis (19). In all cases, however, the mechanisms through which Notch signaling inhibits osteoblast differentiation from the progenitors have not been fully elucidated.
Recent studies have implicated the rewiring of cellular
metabolism in osteoblast differentiation. In particular, Wnt/
Lrp5 signaling, which promotes bone formation in both mice
and humans, has been shown to stimulate aerobic glycolysis
and glutamine catabolism as well as fatty acid oxidation during
jci.org   Volume 128   Number 12   December 2018
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Figure 1. Notch signaling suppresses glycolysis in bone marrow mesenchymal progenitors. (A) Relative mRNA levels of the indicated genes assayed by
RT-qPCR in R26-NICD2 BMSCs infected with Ad-GFP or Ad-Cre and treated with mineralization media for 48 hours. n = 3. (B) AP or von Kossa staining in
R26-NICD2 BMSCs infected with Ad-GFP or Ad-Cre after 4 days or 2 weeks, respectively, in mineralization media. (C) Glucose consumption and lactate production by R26-NICD2 BMSCs infected with Ad-GFP or Ad-CRE in regular growth media for 48 hours. n = 3. (D) Diagram of glycolysis and its key enzymes.
(E) Western blots in R26-NICD2 BMSCs infected with Ad-GFP or Ad-CRE for 24 or 48 hours. Protein levels were normalized to β-actin and designated 1 in
samples infected with Ad-GFP. Quantification (mean ± SD) was determined from 3 independent samples. (F) Glucose consumption and lactate production
from WT BMSCs with or without Jagged1 stimulation for 48 hours. n = 3. (G) Western blots in WT BMSCs with or without Jagged1 stimulation for the indicated durations. Protein levels were normalized to β-actin or tubulin, and quantification (mean ± SD) was determined from 3 independent samples.
*P < 0.05, by 2-tailed Student’s t test (A, C, and E–G). Hk2: hexokinase 2; Pfkfb3/4: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 or 4;
F-2,6-P: fructose 2,6-bisphosphate; Pfk1: phosphofructokinase 1; Eno: enolase; Ldha: lactate dehydrogenase a; Pkm: pyruvate kinase, muscle.

osteoblastogenesis (20–22). In addition, teriparatide, a fragment
(amino acids 1–34) of human parathyroid hormone (PTH) and an
FDA-approved bone anabolic drug, enhances aerobic glycolysis
via the induction of insulin-like factor (Igf) signaling (23). Runx2,
a critical transcription factor for osteoblast differentiation,
appears to engage Glut1, the major glucose transporter in osteogenic cells, in a feed-forward regulation to control osteoblast differentiation and bone formation in the mouse (24). Interestingly,
Notch signaling has been shown to affect cellular metabolism in
other systems. Both hyper- and hypoactivation of Notch induced
a glycolytic phenotype in breast cancer cells through distinct
mechanisms (25). Forced expression of NICD1 in a cell culture
model altered the mitochondrial proteome involved in oxidative
phosphorylation, glutamine catabolism, and fatty acid oxidation
(26). In Drosophila cells, Notch stimulated glycolysis while sup5574
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pressing metabolism through the TCA cycle (27). However, in the
mouse, Notch signaling has been shown to suppress glycolysis in
endothelial cells (28). Notch activation was also linked with the
increase in both glycolysis and mitochondrial oxidative phosphorylation in murine proinflammatory macrophages (29). Thus,
it is likely that Notch controls cellular metabolism in a contextdependent manner. A potential role for the metabolic regulation
of Notch in bone has yet to be explored.
Here, we report that Notch signaling diminished glycolysis
along with suppression of osteoblast differentiation in bone marrow mesenchymal progenitors. Deletion of Notch2 concurrently
increased glycolysis and osteoblast numbers in the mouse. Pharmacological reduction of the glycolytic flux abrogated excessive bone
formation in Notch2-deficient mice. Thus, Notch signaling impedes
bone formation in part through suppression of glucose metabolism.
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Figure 2. Suppression of glycolysis abolishes excessive bone formation caused by Notch2 deletion. (A) Western blots of long bones from 8-week-old
Prx1-Cre Notch2fl/fl (PN2) mice and Notch2fl/fl (N2) littermates. Each lane is for a separate mouse. (B) Glucose consumption and lactate production in N2
and PN2 BMSCs with or without Jagged1 treatment for 48 hours. n = 3. (C–I) Analyses of 7-week-old N2 or PN2 mice that received 3PO or DMSO for 4 weeks
starting at 3 weeks of age, including body weight (C), blood glucose (D), 14C-2DG uptake in bone (E), μCT images (F), μCT quantification (G), and dynamic
histomorphometry (H) of trabecular bone in the proximal tibia, as well as serum CTX-I levels (I). n = 3. *P < 0.05, by 2-way ANOVA followed by Bonferroni’s
post hoc test (C–E, H, and I) or 2-tailed Student’s t test (B and G). BV, bone volume; DPM, disintegrations per minute; TV, total volume.

Results

Notch signaling suppresses glycolysis in bone marrow mesenchymal
progenitors. HCS is caused by abnormal stabilization of the Notch2
ICD (NICD2) following activation of the Notch2 receptor. The
increased half-life of NICD2 probably leads to elevated NICD2 levels and a prolonged Notch response in the cell. To model this aspect
of HCS, we overexpressed NICD2 in primary cultures of bone marrow stromal cells (BMSCs). Specifically, we used the R26-NICD2
mouse, which was genetically engineered to express NICD2 from
the ubiquitously active Rosa26 locus upon Cre recombination (30).
Briefly, BMSCs were cultured from young adult mice harboring the
R26-NICD2 allele and infected with adenovirus expressing either
Cre (Ad-Cre) or GFP as a control (Ad-GFP). As BMSCs contain
mesenchymal progenitors with the potential to become osteoblasts, we assessed the effect of NICD2 overexpression on osteoblastogenesis in response to ascorbic acid and β-glycerophosphate.
After 48 hours of treatment, NICD2 induced the Notch target genes

Hey1, Hey2, and Hes1, but markedly suppressed expression of the
osteoblast markers Alpl, Bsp, Bglap, and Sp7 in BMSCs (Figure 1A).
After 4 days or 2 weeks of differentiation, the Ad-Cre–infected
cells showed less alkaline phosphatase (AP) or von Kossa staining,
respectively, than did the control cells (Figure 1B). Thus, sustained
Notch2 signaling suppresses osteoblast differentiation from bone
marrow mesenchymal progenitors.
In light of recent evidence implicating glucose metabolism in osteoblast differentiation, we investigated the effect of
Notch2 activation on glycolysis. When BMSCs from R26-NICD2
mice were infected with Ad-Cre or Ad-GFP, those infected with
Ad-Cre consumed less glucose and secreted less lactate after 48
hours (Figure 1C). To assess the biochemical basis for the glycolytic suppression, we examined the abundance of several enzymes
controlling key steps of glycolysis (Figure 1D). Among those, Pfkfb3 and Pfkfb4 increase the amount of fructose-2,6-bisphosphate
(F-2,6-P) that stimulates the activity of phosphofructokinase Pfk1,
jci.org   Volume 128   Number 12   December 2018
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lated in the bones of PN2 mice,
consistent with reduced Notch
signaling (31) (Supplemental
Genotype
BV/TV (%)
Tb.N (1/mm)
Tb.Th (mm)
Tb.Sp (mm)
fl/fl
Figure 1). Western blotting
Notch2 /DMSO
18.1 ± 1.108
4.16 ± 0.335
0.0679 ± 0.002
0.240 ± 0.025
revealed a notable increase in
12.1 ± 2.661A
2.81 ± 0.537A
0.0613 ± 0.006A
0.365 ± 0.079A
Notch2fl/fl/3PO
Pfkfb3, Pkm1, Pkm2, and Ldha
Prx1-Cre Notch2fl/fl/DMSO
22.9 ± 0.694B
4.74 ± 0.279B
0.0716±0.005B
0.198 ± 0.016 B
in the bone protein extracts of
Prx1-Cre Notch2fl/fl/3PO
12.5 ± 3.055C
3.31 ± 0.312C
0.0629 ± 0.005 C
0.303 ± 0.034C
Values represent the mean ± SD. Tb.N, number of trabeculae; Tb.Th, trabecular thickness; Tb.Sp, trabecular spacing. PN2 versus their N2 littermates
(Figure 2A). To confirm that
n ≥ 6 for each group. A,B,CP < 0.05, for statistically significant effects for A3PO, BCre, and C3PO-Cre interaction, as
Notch2 was a major receptor
determined by 2-way ANOVA.
in suppressing glycolysis, we
evaluated the effect of Jagged1
on glycolysis in BMSCs from
whereas Ldha helps to sustain glycolysis by regenerating NAD+,
N2 versus those from PN2 mice. While the N2 BMSCs showed an
obvious decrease in glucose consumption and lactate secretion in
while converting pyruvate to lactate. Infection of the BMSCs with
response to Jagged1, the PN2 BMSCs showed no such response
Ad-Cre notably reduced Pfkfb3 and Pfkfb4 after 24 or 48 hours
(Figure 2B). Thus, Notch2 is a major receptor for mediating the
and also decreased Ldha levels after 48 hours (Figure 1E). Thus,
suppression of both bone formation and glycolysis in bone cells.
Notch2 activation concurrently suppresses glycolysis and osteoWe next assessed whether increased glycolysis contributes
blast differentiation in bone marrow mesenchymal progenitors.
to the excessive bone formation caused by Notch2 deletion. The
To corroborate the metabolic regulation by Notch signaling,
small molecule 3PO is a cell-permeable inhibitor of Pfkfb3, which
we activated the pathway in WT BMSCs with recombinant Jagnormally produces 2,6-bisphosphofructose, a potent activator of
ged1 immobilized on the culture dish. After 48 hours of culture,
glycolysis (32). We found that treatment of mice with 3PO for 1
we found that Jagged1 suppressed glucose consumption and lacmonth did not significantly change their body weights or cause any
tate secretion when compared with the control Fc (Figure 1F).
obvious distress to the mice (Figure 2C). Treatment with 3PO also
Biochemically, Jagged1 reduced the abundance of Pfkfb3, Pfkfb4,
did not impair glucose homeostasis, as indicated by the normal
and Ldha after 24 or 48 hours of culture (Figure 1G). In addition,
fasting blood glucose levels in the mice (Figure 2D). To monitor the
after 48 hours, Jagged1 suppressed the pyruvate kinases Pkm1 and
potential effect of Notch2 deletion or 3PO on glucose metabolism
Pkm2 that control the last step of glycolysis, without affecting the
in bone, we performed glucose uptake assays in vivo by injecting
hexokinase Hk2 (Figure 1G). Thus, as with Notch2 overexpression,
14
Notch activation by Jagged1 suppresses glycolysis in bone marrow
C-labeled 2-deoxyglucose (2-DG). The results showed a clear
mesenchymal progenitors.
increase in 2-DG uptake in the bones of PN2 mice compared with
Suppression of glycolysis abolishes the excessive bone formauptake in N2 mice under the control conditions (DMSO injection).
tion caused by Notch2 deletion. We next tested the contribution
Moreover, the month-long 3PO treatment significantly reduced
of glycolysis to the effect of Notch signaling on bone formation.
2-DG uptake in the bones of both PN2 and N2 mice (Figure 2E).
We have previously demonstrated that deletion of Notch2 with
Importantly, 3PO significantly reduced the cancellous bone mass
Prx1-Cre enhances bone formation in the long bones (31). Here,
in both N2 and PN2 mice (Figure 2F). As a result, 3PO completely
we recreated Prx1-Cre Notch2fl/fl (PN2) mutant mice by breedabolished the high-bone-mass phenotype in PN2 mice and rendered the cancellous bone mass indistinguishable between the 2
ing Prx1-Cre Notch2fl/+ males with Notch2fl/fl females. Reverse
genotypes (Figure 2G and Table 1). 3PO also reduced cortical bone
transcription quantitative PCR (RT-qPCR) analyses with total
volume without affecting tissue volume in both N2 and PN2 mice
RNA extracted from cortical bone confirmed that Notch2 mRNA
(Table 2). Dynamic histomorphometry revealed that 3PO reduced
expression was reduced by 50% in the PN2 mice compared with
both the mineral apposite rate (MAR) and the mineralizing surface
expression in the Notch2fl/fl (N2) mice (Supplemental Figure 1;
over bone surface (MS/BS) percentage, regardless of genotype,
supplemental material available online with this article; https://
thereby completely eliminating the significant increase in bone fordoi.org/10.1172/JCI96221DS1). On the other hand, Nfatc1, a
mation rate over bone surface (BFR/BS) caused by Notch2 deletion
known target of the Hey transcriptional repressors, was upregu-

Table 1. μCT analyses of trabecular bone in proximal tibiae

Table 2. μCT analyses of cortical bone in proximal tibiae
Genotype

BV/TV (%)

Tt.Ar (mm2)

Ct.Ar (mm2)

Ct.Ar/Tt.Ar (%)

Cortical ThA (mm)

Notch2fl/fl/DMSO
Notch2fl/fl/3PO
Prx1-Cre Notch2fl/fl/DMSO
Prx1-Cre Notch2fl/fl/3PO

62.6 ± 2.2
58.6 ± 2.6A
64.8 ± 2.1
58.9 ± 3.1B

0.94 ± 0.09
0.76 ± 0.10
0.90 ± 0.07
0.75 ± 0.11

0.59 ± 0.04
0.45 ± 0.07A
0.58 ± 0.04
0.44 ± 0.08B

62.6 ± 2.2
58.6 ± 2.6A
64.8 ± 2.2
58.9 ± 3.1B

0.20 ± 0.007
0.17±0.018A
0.21 ± 0.010
0.17 ± 0.021B

Values represent the mean ± SD. Tt.Ar, total area; Ct.Ar, cortical area; Cortical Th, cortical thickness. n ≥ 6 for each group. A,BP < 0.05, for statistically
significant effects for A3PO and B3PO-Cre interaction, as determined by 2-way ANOVA.

5576
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Figure 3. Notch2 signaling suppresses glycolysis in ST2 cells. (A) Glucose consumption and lactate production by GFP-ST2 or NICD2-ST2 cells treated with
vehicle or Dox for 48 hours. n = 3. (B–D) Seahorse analyses of NICD2-ST2 cells treated with vehicle or Dox for 48 hours. n = 10. (E) Relative ATP levels in
NICD2-ST2 cells treated with vehicle or Dox for 48 hours. n = 6. (F) Glucose uptake assays in NICD2-ST2 cells treated with vehicle or Dox for the indicated
durations. n = 6. (G) Western blots of NICD2-ST2 cells treated with vehicle or Dox for the indicated durations. β-Actin was used for normalization and quantification (mean ± SD) was determined from 3 independent samples. After normalization to β-Actin, the levels in “-Dox” lanes were designated 1 and those
in the “+Dox” lanes were further normalized. *P < 0.05, by 2-tailed Student’s t test (A and D–G).

(Figure 2H). On the other hand, 3PO did not significantly increase
the levels of the C-terminal telopeptide of type I collagen (CTX-I)
in the serum of either N2 or PN2 mice, indicating a relatively small
effect on bone resorption (Figure 2I). To confirm the direct effect
of 3PO on osteoblast differentiation, we cultured primary BMSCs
from PN2 and N2 mice on Jagged1-treated plates in osteogenic
media with or without 3PO. Jagged1 suppressed the expression of
the osteoblast markers Alpl, Ibsp, Runx2, and Bglap in N2 BMSCs
but did not have a similar effect on PN2 BMSCs (Supplemental
Figure 2). In fact, Jagged1 resulted in a slight increase in Alpl and
Ibsp mRNA expression in the PN2 BMSCs for reasons unknown at
present. Importantly, 3PO suppressed the expression of all markers
in both N2 and PN2 BMSCs cultured with Jagged1, indicating that
Pfkfb3 functionally interacts with Notch in regulating osteoblast
differentiation in vitro (Supplemental Figure 2). Thus, both in vivo
and in vitro evidence identifies Pfkfb3 as a key mediator for the
suppression of osteoblast differentiation by Notch.
Canonical Notch signaling suppresses glycolysis. To gain further
insights into the regulation of glucose metabolism, we chose to
activate Notch signaling in ST2 cells, a bone marrow mesenchy-

mal progenitor cell line derived from adult mice. The choice of
the cell line allowed us to establish stable clones expressing either
NICD2 or GFP (termed NICD2-ST2 or GFP-ST2 cells, respectively) in response to doxycycline (Dox). Expression of NICD2, but
not GFP, reduced both glucose consumption and lactate secretion
by ST2 cells after 48 hours of Dox induction (Figure 3A). Seahorse
analyses confirmed that induction of NICD2 for 48 hours suppressed the extracellular acidification rate (ECAR), with or without the mitochondria stressors (Figure 3B). NICD2 also reduced
the oxygen consumption rate (OCR) in both basal conditions and
in response to the uncoupling reagent FCCP (Figure 3C). Quantification of the OCR data revealed a decrease in both ATP production from mitochondrial respiration and the spare respiratory
capacity upon NICD2 expression (Figure 3D). Biochemical measurements revealed a notable reduction in steady-state intracellular ATP levels in response to 48 hours of Dox treatment (Figure
3E). In keeping with reduced glucose consumption, incubation of
the cells with the fluorescent glucose analog 2-NBDG revealed
that NICD2 began to suppress glucose uptake after 12 hours of
Dox treatment (Figure 3F). Western blot analyses showed that
jci.org   Volume 128   Number 12   December 2018

5577

RESEARCH ARTICLE

The Journal of Clinical Investigation  

Figure 4. Canonical Notch signaling suppresses glycolysis. (A–C) Effects of retroviral expression of GFP or dnMaml1 on glucose consumption (A), lactate
production (B) or metabolic enzymes (C) in NICD2-ST2 cells treated with vehicle or Dox for 48 hours. β-Actin was used for normalization, and quantification
(mean ± SD) was determined from 3 independent samples. After normalization to β-Actin, the level in the left-most lane is designated 1, and those of the
other lanes are further normalized to the left-most lane. (D) Glucose consumption and lactate production in Hey1-ST2 cells treated with vehicle or Dox for
48 hours. Western blot shows the induction of Flag-Hey1 by Dox. n = 3. (E) Relative mRNA levels of NFATc1 by RT-qPCR in Hey1-ST2 cells treated with vehicle or Dox for 48 hours. n = 3. (F) RT-qPCR analyses of Hey1 in NICD2-ST2 cells infected with lentivirus expressing 2 different Hey1 shRNAs or the control
luciferase shRNA (shLuc). (G) Glucose consumption and lactate production in NICD2-ST2 cells infected with lentivirus expressing different shRNAs, with
or without Dox for 48 hours. (H) Relative glucose consumption in NICD2-ST2 cells infected with lentivirus expressing different shRNAs, with or without
Dox for 48 hours. Glucose consumption was normalized to the protein amount and then to the vehicle-treated group designated as 1. (I) RT-qPCR analyses
of mRNA levels showing shRNA knockdown efficiency. n = 3. *P = 0.05, by 2-way ANOVA followed by Bonferroni’s post hoc test (A, B, F, and I) or 2-tailed
Student’s t test (C, E, G, and H).

NICD2 reduced both Pfkfb3 and Ldha after 12 hours of induction
(Figure 3G). Thus, as with Notch activation in the primary bone
marrow mesenchymal cells, sustained Notch2 signaling in ST2
cells suppressed glycolysis.
We next assessed the potential role of canonical Notch signaling in the regulation of metabolism. Specifically, we tested
the effect of dominant-negative Maml1 (dnMaml1), which has
been well established as an inhibitor of the canonical Notch signaling pathway (33). Retroviral expression of dnMaml1, but not
GFP, completely eliminated the suppression of glucose consumption by NICD2 and partially restored the production of lactate
(Figure 4, A and B). Consistent with metabolic rescue, dnMaml1
restored Pfkfb3 and Ldha expression to normal levels in response
5578
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to NICD2 (Figure 4C). It is worth noting that dnMaml1 alone did
not affect glucose consumption, lactate production, or the metabolic enzymes, confirming the specific antagonism of dnMaml1
on Notch2 signaling. Thus, Notch2 signaling suppresses glucose
metabolism through a Maml1-dependent mechanism.
Given that the Hes/Hey transcriptional repressors are the
prototypical mediators of canonical Notch signaling, we examined whether they were responsible for metabolic regulation.
We focused on Hey1, as our earlier results showed that it was the
most robustly induced by NICD2 among the Hes and Hey genes
in BMSCs (Figure 1A). To this end, we generated a stable ST2 cell
line expressing Hey1 in response to Dox. However, Hey1 expression did not affect glucose consumption or lactate production,

The Journal of Clinical Investigation  
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Figure 5. Canonical Notch signaling suppresses gene expression of glycolytic enzymes and components of the mitochondrial ETC. (A and B) Relative
mRNA levels of glycolytic enzymes (A) and components of the mitochondrial ETC (B) in NICD2-ST2 cells with retroviral expression of GFP or dnMaml1 and
treatment with vehicle or Dox for 24 hours. (C) Relative glucose consumption in NICD2-ST2 cells infected with lentivirus expressing different shRNAs, as
indicated, with or without Dox for 48 hours. Glucose consumption was normalized to the protein amount and then to the no-Dox control designated as 1.
n = 3. *P < 0.05, by 2-way ANOVA followed by Bonferroni’s post hoc test (A and B) or 2-tailed Student’s t test (C).

even though it suppressed the mRNA levels of NFATc1, which was
previously identified as a Hey1 target gene (Figure 4, D and E)
(31). To further test the potential relevance of Hey1, we knocked
down its expression in NICD2-ST2 cells with shRNA expressed
from a lentiviral vector. Whereas Dox markedly induced Hey1 in
cells expressing the control shRNA targeting the luciferase gene
(shLuc), 2 independent Hey1 shRNA constructs (Hey1_1 and
Hey1_2) diminished the induction of Hey1 by more than 80%
(Figure 4F). However, neither construct showed any effect on the
suppression of glucose consumption or lactate secretion by Dox
in NICD2-ST2 cells (Figure 4G). Therefore, induction of the Hes/
Hey proteins does not appear to be the main mechanism mediating metabolic regulation by Notch.
To gain further insights into the mechanism underlying glycolytic suppression by Notch, we performed RNA-Seq experiments
using NICD2-ST2 cells with or without Dox treatment for 24 hours.
Among the genes with mRNA levels changed by a minimum of
20%, the prototypical Notch target genes, including Hes1, Hes6,
Hey1 and Hey2, were induced by NICD2. However, like that of

Hey1, effective knockdown of Hey2, Hes1, or Hes6 did not alleviate
the suppression of glucose consumption caused by NICD2 overexpression (Figure 4, H and I). Importantly, several suppressed genes
encode glycolytic enzymes including Pfkfb2, Pfkfb3, Pfkfb4, Eno2,
Eno3, and Ldha, while several others, such as Ndufaf2, Ndufc1,
Ndufs5, and Ndufaf4 of complex I, and Ndufa4 of complex IV,
code for components of the mitochondrial electron transport chain
(ETC). RT-qPCR experiments confirmed the suppression of those
genes by NICD2 (Supplemental Figure 3). Furthermore, dnMaml1,
which was shown earlier to negate the metabolic effect of Notch,
either abolished or alleviated the suppression of glycolytic or ETC
genes by NICD2 (Figure 5, A and B). Thus, transcriptional suppression of both glycolytic and mitochondrial ETC genes may contribute to the restriction of glycolysis by Notch.
To explore the mechanism whereby canonical Notch signaling suppresses metabolic gene expression, we investigated the
potential role of transcriptional repressors beyond the Hes/Hey
family. RNA-Seq experiments identified 14 additional known
repressors that were induced by at least 2-fold and that had an
jci.org   Volume 128   Number 12   December 2018
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Table 3. Role of transcriptional suppressors in glycolytic
suppression by Notch
Gene name

Role

Cbfa2t3
Hr
Lmcd1
Tcf7l2
Nab1
Hey1
Hey2
Hes1
Hes6
Msx1
Zfp703
Foxs1
Nfatc4
Btg2
Cobra1
Brms1
Tle1
Bach1

Yes
Yes
Yes
Yes
Yes
No
No
No
No
No
No
No
No
No
No
No
No
No

induced level of more than 10 reads per kb per million mapped
reads (RPKM) upon NICD2 expression over a 24-hour period in
ST2 cells. RT-qPCR experiments confirmed the induction of the
repressors by NICD2 after 24 hours and, further, that their induction was abolished by the viral expression of dnMaml1. We then
systematically knocked down each repressor with 2 independent
shRNAs in NICD2-ST2 cells and measured glucose consumption
with or without Dox induction over a 48-hour period. The results
showed that knockdown of Cbfa2t3, Hr, Lmcd1, Tcf7l2, or Nab1
essentially eliminated glycolytic suppression by NICD2, whereas
the other repressors did not have the same effect (Figure 5C and
Supplemental Figure 4) (Table 3). Thus, it is likely that canonical
Notch signaling induces the expression of multiple transcriptional
repressors to suppress glycolysis.
Notch suppresses glycolysis through downregulation of AMPK
activity. The suppression of complex I genes by Notch2 prompted
us to examine the potential role of complex I in metabolic regulation. NICD2 expression in response to Dox for 24 hours reduced
the activity of complex I in NICD2-ST2 cells (Figure 6A). Consistent with complex I being a major producer of mitochondrial
superoxide, we found that NICD2 decreased the level of mitochondrial superoxide after 12 or 24 hours of Dox induction (Figure
6B). These results are consistent with our earlier observation that
NICD2 expression reduced overall oxygen consumption (Figure
3C). Overall, Notch2 signaling suppresses mitochondrial respiration and the production of ROS.
Recent studies have demonstrated that mitochondrial superoxide activates adenosine 5′-monophosphate–activated protein
kinase (AMPK) through H2O2 (34). Because of the essential role of
AMPK in cellular metabolism, we examined its potential relevance
to glycolytic suppression by Notch. As a heterotrimeric kinase
composed of α, β, and γ subunits, AMPK activation correlates with
phosphorylation at Thr172 on the α subunit (35). We found that
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phosphorylation at Thr172 was reduced in ST2 cells upon NICD2
expression for 12 or 48 hours and observed the same kinetics as
that for the suppression of glucose uptake (Figure 6C, compare
with Figure 3F). Importantly, dnMaml1, shown above to abolish
the metabolic effect of NICD2, also restored the phosphorylation
of AMPK and acetyl-coA carboxylase (ACC), a prototypical substrate of AMPK (Figure 6, D and E). The suppression of AMPK by
Notch was confirmed in WT BMSCs, as Jagged1 reduced the levels
of phosphorylated AMPKα (p-AMPKα) and p-ACC (Figure 6F). To
test the functional relevance of AMPK suppression to Notch function, we force-activated the enzyme with the AMP analog AICAR.
At either 50 or 100 μM, AICAR did not affect basal glucose consumption or lactate secretion by BMSCs but abolished the suppression by Jagged1 (Figure 6G). Likewise, 100 μM AICAR overcame
the suppression of glucose consumption and lactate secretion by
Dox-induced NICD2 expression in the NICD2-ST2 cells (Figure
7A). However, AICAR had little to no effect on mRNA levels of the
glycolytic genes that were suppressed by NICD2 (Figure 7B). Thus,
we found that force-activation of AMPK was sufficient to counteract the glycolytic suppression by Notch, without affecting glycolytic gene expression. This observation is consistent with previous
reports that AMPK phosphorylates Pfkfb3 to increase its enzymatic activity and hence glycolysis. Finally, to test whether the suppression of complex I genes was sufficient to reduce AMPK activity, we knocked down Ndufaf2, which was suppressed by Notch,
and assayed for AMPK phosphorylation. We found that 2 independent shRNAs effectively reduced Ndufaf2 mRNA expression and
decreased p-AMPKα levels relative to total AMPK levels (Figure
7C). Taken together, the results support a model in which canonical Notch signaling induces multiple transcriptional repressors to
suppress both glycolytic and mitochondrial ETC genes. Whereas
the former reduces the abundance of glycolytic enzymes, the latter results in decreased AMPK activity that probably restricts the
activity of the enzymes (Figure 8).

Discussion

We have provided evidence that Notch signaling suppresses glucose metabolism in mesenchymal progenitors to inhibit osteoblast differentiation. The mechanism of the metabolic regulation
by Notch involves the transcriptional downregulation of multiple
metabolic genes integral to glycolysis or the mitochondrial ETC.
The decrease in mitochondrial respiration in turn reduces ROS
production and AMPK activity, resulting in further suppression
of glycolysis. We believe that these results shed new light on the
mechanism through which Notch regulates bone physiology.
Exactly how Notch signaling suppresses metabolic genes is
not clear at present. The data clearly indicate the importance of
the Maml proteins, thus implicating canonical Notch signaling
in metabolic regulation. However, since the NICD-Maml-Rbpjk
complex is known to activate gene expression, the gene suppression we observed must be indirect. Although Hes/Hey transcription suppressors are prototypical mediators for Notch, they are
unlikely to be the main driver for metabolic suppression, as overexpression of Hey1 did not impair glycolysis, and knockdown of
the relevant Hes/Hey genes did not blunt the Notch effect. On the
other hand, 5 transcriptional repressors induced by NICD2 contributed to the glycolytic suppression, but future experiments are
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Figure 6. Notch suppresses glycolysis through downregulation of AMPK activity. (A–C) Measurements of mitochondrial complex I activity (n = 4) (A),
mitochondrial superoxide levels (n = 6) (B), and p-AMPKα levels (n = 3) (C) in NICD2-ST2 cells treated with vehicle or Dox for the indicated durations. Total
AMPKα was used for normalization, and quantification (mean ± SD) was determined from 3 independent samples. After normalization to total AMPKα,
the level in the left lane was designated 1 and that of the right lane was further normalized to the left lane. mOD, mitochondrial OD. (D and E) Western
blot analyses of NICD2-ST2 cells with retroviral expression of GFP or dnMaml1 and treatment with vehicle or Dox for 24 hours. Phosphorylation levels were
normalized to total AMPKα or ACC, and quantification (mean ± SD) was determined from 3 independent samples. After normalization to total protein, the
level in the left-most lane was designated 1 and the other lanes were further normalized to that lane. (F) Western blots of BMSCs with or without Jagged1
stimulation for 24 hours. Normalization and quantification were determined as in D and E. (G) Effects of AICAR at the indicated concentration for 48 hours
on glucose consumption and lactate production in BMSCs with or without Jagged1 stimulation. n = 3. *P < 0.05, by 2-tailed Student’s t test (A–G).

necessary to establish the potential direct suppression of glycolytic
or ETC genes by any of the repressors implicated here.
The current study highlights the fact that metabolic regulation by Notch is highly dependent on cellular context. A previous
study has shown that Notch induces the transcription of Glut1,
hexokinase A (Hex-A), and Impl3 (Ldha homolog) in Drosophila
cells, resulting in a Warburg-like effect (27). However, RNA-Seq
detected no change in Glut1, Hk1, or Hk2 upon expression of
NICD2 in ST2 cells. On the contrary, we observed a downregulation of Ldha and other key glycolytic enzymes and, consequently,
a suppression of glycolysis by Notch. Another study using mouse
macrophages indicated that Notch stimulates mitochondrial oxidative phosphorylation in part through the transcriptional induction of pyruvate dehydrogenase phosphatase catalytic subunit 1
(Ppd1) to promote the M1 phenotype (29). However, we observed
a notable decrease in both Pdp1 (–1.7-fold) and Pdp2 (–2.6-fold) in
ST2 cells after 24 hours of NICD2 expression. On the other hand,
our finding about the suppressive role of Notch in glucose metabolism is reminiscent of that previously reported in endothelial cells,
in which Notch reduced Pfkfb3 and glycolytic flux (28). Overall,
although the exact reason for the different effects of Notch on glu-

cose metabolism is not known, they likely reflect the specific epigenetic landscape and signaling network in each cell type.
The current study further strengthens the link between bone
formation and cellular metabolism. Previous studies have demonstrated that Wnt, PTH, and Igf signaling stimulates glycolysis and
glutamine catabolism while increasing bone accrual (36). Here,
Notch suppressed osteoblast differentiation, at least in part through
the restriction of glucose metabolism. Together, these findings indicate that metabolic rewiring plays an integral role in the regulation of
bone formation and, further, that targeting metabolic pathways may
be a promising avenue for the development of novel bone therapies.

Methods

Mouse strains. Notch2fl/fl, R26-NICD2, and Prx1-Cre mouse strains
were generated as previously described (30, 37, 38). We thank Ryuichi
Nishinakamura (Kumamoto University, Japan) for providing the R26NICD2 mouse strain. All mice were housed in a specific pathogen–free
(SPF) barrier facility managed by the Department of Comparative
Medicine of Washington University. The animals were group housed
under a 12-hour light cycle (6 am–6 pm) and fed standard chow (PicoLab Mouse Diet 20, product 5058).
jci.org   Volume 128   Number 12   December 2018
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Figure 7. AMPK activation rescues metabolic inhibition by Notch2 without restoring glycolytic gene expression. (A) Effects of AICAR for 48 hours on
glucose consumption and lactate production in NICD2-ST2 cells. (B) RT-qPCR analyses of relative mRNA levels of glycolytic genes. (C) Western blot and RTqPCR analyses of ST2 cells infected with lentivirus expressing shRNAs targeting luciferase (Luc) or Ndufaf2. pAMPK was first normalized to total AMPK in
each lane. The normalized level in the left -most lane was designated 1 and those of the other lanes were further normalized to that lane. All RT-qPCR data
were normalized to 18S rRNA. n = 3. *P < 0.05, by 2-way ANOVA followed by Bonferroni’s post hoc test (A) or 2-tailed Student’s t test (B and C).

Analyses of bone. For 3PO treatment, mice were injected i.p. with
the chemical (MilliporeSigma, 525330) dissolved in DMSO at 50 mg/
kg body weight or an equal volume of DMSO as a control daily beginning on P24 for 4 weeks. Micro-CT (μCT 40, Scanco Medical AG)
was performed on tibiae. Quantification of the cancellous bone was
assessed by measuring 100 μCT slices (1.6 mm) immediately below
the growth plate, with a threshold of 200. For cortical bone parameters, 50 μCT slices (0.8 mm) from the mid-shaft of the tibia were analyzed, with a threshold of 260.
For dynamic histomorphometry, calcein (MilliporeSigma) dissolved in water (pH 7.2–7.4, adjusted with NaOH) was injected i.p. at
7.5 mg/kg body weight on days 7 and 2, respectively, prior to sacrifice.
Bones were fixed in 70% ethanol, embedded in methyl-methacrylate,
and sectioned at 10-μm thickness. Histomorphometric parameters
were acquired with a BIOQUANT Osteo II from 3 sections per mouse
and 3 mice for each genotype.
In vivo glucose uptake assay. Mice injected with 3PO or DMSO
vehicle for 4 weeks were first examined for serum glucose levels. For
this, blood samples were collected through the tail vein after the mice
were starved for 3 hours, and blood glucose levels were measured
with a glucose meter (Ascensia Contour; Bayer). The mice were rested
for 30 minutes before being injected i.p. with 14C-2DG (PerkinElmer,
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NEC495A001MC) at 10 μCi per 20 g body weight and then sacrificed
after 2 hours for collection of tibiae and femurs. The growth plates
were surgically removed with a scalpel under the microscope before
the bone marrow was cleared through centrifugation. The remaining
trabecular and cortical bone was weighed, chopped with surgical scissors, and then lysed in RIPA buffer for 30 minutes on ice. After centrifugation, the supernatant was collected for scintillation counting.
Serum biochemical assays. For serum CTX-I or P1NP assays, serum
was collected through retro-orbital bleeding from mice starved for
6 hours, and the serum was analyzed with the RatLaps ELISA Kit
(Immunodiagnostic Systems Ltd., AC-06F1) or the Rat/Mouse PINP
EIA Kit (Immunodiagnostic Systems Ltd., AC-33F1) according to the
manufacturers’ instructions.
Western blot analysis. ST2 cells or mouse primary BMSCs were harvested in lysis buffer (50 mM TrisCl, 150 mM NaCl, 1% NP-40, 5 mM
EDTA, 5% glycerol) containing proteinase inhibitors and phosphatase
inhibitors (Thermo Fisher Scientific, catalog 78442). To extract bone
proteins, femurs and tibiae were pulverized in liquid nitrogen after
surgical removal of the epiphysis and flushing of the marrow. The
bone powders were harvested in the lysis buffer and centrifuged to
collect the soluble proteins that were later quantified with the Micro
BCA Protein Assay Kit (Thermo Fisher Scientific). Total protein (10 μg)
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Figure 8. Working model for Notch signaling in the suppression of glucose metabolism in mesenchymal progenitors.
Canonical Notch signaling induces multiple transcriptional
repressors that suppress the transcription of genes encoding
glycolytic enzymes or mitochondrial complex I components.
The decrease in mitochondrial respiration lowers AMPK activity and helps to reduce glycolysis.

was resolved by electrophoresis on Mini-PROTEAN TGX Precast
Gel (Bio-Rad), transferred onto a 0.45-μm pore PVDF Immobilon-P
membrane (MilliporeSigma), and detected with a specific antibody
against Ldha (product no. 2012), AMPKα (product no. 2531), p-AMPKα
(product no. 2532), β-actin (product no. 4970), Pkm2 (product no.
4053), p-ACC (product no. 3661), or ACC (product no. 3676) (all purchased from Cell Signaling Technology); or an antibody against Pfkfb4
(product no. PAB4031) from Novus Biologicals; or Pkm1 (product no.
SAB4200094) from MilliporeSigma. Membranes were blocked for 1
hour at room temperature in 5% BSA (Roche) or 5% milk (Bio-Rad) in
TBS containing 0.1% Tween-20 (TBST), followed by overnight incubation at 4°C with the primary antibody. Then, the membranes were
washed with TBST and further incubated at room temperature for 1.5
hours with an HRP-conjugated anti-rabbit (GE Healthcare, product
no. NA934V) or anti-mouse (Cell Signaling Technology, product no.
7076S) secondary antibody. All blots were developed using the Clarity Substrate Kit (Bio-Rad). Gel images were captured with ChemiDoc
(Bio-Rad). Each experiment was repeated with a minimum of 3 independently prepared protein samples.
Generation of Dox-inducible stable cell lines. To generate the TetOFUW-FlagNICD2-IRES-EGFP lentiviral construct, we first created the
vector TetO-FUW-polylinker by replacing cMYC in the TetO-FUWcMYC plasmid (Addgene plasmid 20324) with a polylinker containing
EcoRI, AscI, AsisI, AfeI, PacI, SwaI, SbfI, and XbaI. We then released
3xFlag-NICD2 from p3xFlag-CMV-NICD2(Met1669-Ala2470) with
EcoRI and SmaI and inserted it into the EcoRI and AfeI sites of TetOFUW-polylinker (39). Subsequently, IRES-EGFP amplified by PCR
from pCIG was inserted into the PacI and XbaI sites of the polylinker to
produce the final construct TetO-FUW-FlagNICD2-IRES-EGFP (40).
To make the TetO-FUW-FlagHey1-IRES-EGFP plasmid, we
first inserted Hey1 cDNA into the XbaI and BamHI sites of p3xFlagCMV-7 (MilliporeSigma) to produce p3xFlag-CMV-Hey1. We then
released 3xFlag-Hey1 from p3xFlag-CMV-Hey1 with EcoRI and SmaI
and inserted it into the EcoRI and AfeI sites of TetO-FUW-polylinker.
Finally, IRES-EGFP was inserted in the same way as described above.
Lentiviruses were produced according to a standard protocol.
Briefly, 293T cells were transfected with FUW-M2rtTA (Addgene

plasmid 20342), TetO-FUW-FlagNICD2-IRES-EGFP or TetO-FUWFlagHey1-IRES-EGFP, together with psPAX2 and pMD2.G. After overnight incubation, the cells we placed into fresh media that was then
harvested for viruses after 2 days.
To produce the stable cell lines, ST2 cells were coinfected with the
FUW-M2rtTA virus, together with either the TetO-FUW-FlagNICD2IRES-EGFP or the TetO-FUW-FlagHey1-IRES-EGFP virus. The cells
were then plated at single-cell density in 96-well plates for colony
selection. The positive clones were identified on the basis of green
fluorescence expression and Western blotting in the presence of Dox.
Cell culture. ST2 cells and BMSCs were grown in αMEM (Gibco, Thermo Fisher Scientific), and 293T cells were grown in DMEM

Table 4. Primers used for RT-qPCR
Gene name
Alpl
Bglap
BSP
18S
Eno2
Eno3
Hey1
Hey2
Hes6
Hes7
Ldha
Ndufa4
Ndufaf2
Ndufc1
NFATc1
Pfkfb2
Pfkfb3
Pfkfb4
Sp7

Forward sequence(5′–3′)

Reverse sequence (5′–3′)

ACACCAATGTAGCCAAGAATGTCA
TGCTGGAGTGGTCTCTATGA
CCGGCCACGCTACTTTCTT
CGGCTACCACATCCAAGGAA
CAGGACTTTGTCCGGAACTATC
GAACTCCGAGATGGAGACAAAG
CACTGCAGGAGGGAAAGGTTAT
CATGTCGCCTATCCACATCTT
CGGATCAACGAGAGTCTTCAG
CATCAACCGCAGCCTAGAA
TGGAAGACAAACTCAAGGGCGAGA
CCCAGCTTGATTCCTCTCTTC
ACTGGAGAGGGCAGACTATT
CATCTTCATTGTGTGTTTGGATGA
GAGACAGACATCGGGAGGAAGA
GACTGCAACAGCAGCTATAAAC
CTACCTCAACTGGATAGGTGTTC
CATCCAGAGTCGCATCGTTTA
GGAAAGGAGGCACAAAGAAGC

GATTCGGGCAGCGGTTACT
ACCCTCTTCCCACACTGT
GGACTGGAAACCGTTTC
GCTGGAATTACCGCGGCT
AGGTCATCGCCCACTATCT
GGACCTAGAGTCTTGTTGATGTG
CCCCAAACTCCGATAGTCCAT
GGCATCCGAAGAGCAGAAT
CACGGTCAGCTCCAGAAC
GAACTCCAGTATCTCCGCTTTC
TGACCAGCTTGGAGTTCGCAGTTA
GGCTCTGGGTTGTTCTTTCT
GGTGGAGTCTTCCTTGTTCTTC
TCAACACGGTCGAAGTTCTATG
GTGGGATGTGAACTCGGAAGA
GCTGGCAAGCCAATCATAAC
AGGGCGGAAGAAGTTGTAAG
CTTGAGGTTTAGCTCGCTCTC
CCCCTTAGGCACTAGGAG
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Table 5. shRNA targeting sequences
Gene name
Cbfa2t3
Hr
Msx1
Zfp703
Foxs1
Lmcd1
Nfatc4
Btg2
Cobra1
Brms1
Tle1
Bach1
Tcf7l2
Nab1
Ndufaf2

TRC number

shRNA ID code

Sequence (5′–3′)

TRCN0000096429
TRCN0000096430
TRCN0000085998
TRCN0000086000
TRCN0000070623
TRCN0000070627
TRCN0000256674
TRCN0000256675
TRCN0000433258
TRCN0000084998
TRCN0000098786
TRCN0000098789
TRCN0000075340
TRCN0000075341
TRCN0000231223
TRCN0000231220
TRCN0000126520
TRCN0000126519
TRCN0000039282
TRCN0000039281
TRCN0000236783
TRCN0000236782
TRCN0000084279
TRCN0000288208
TRCN0000012180
TRCN0000012178
TRCN0000096136
TRCN0000351197
TRCN0000265502
TRCN0000254242

1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2

CCGGGCAAACAAGCTACTTAGAAATCTCGAGATTTCTAAGTAGCTTGTTTGCTTTTTG
CCGGCGACAAGAAGAAGTGATTGATCTCGAGATCAATCACTTCTTCTTGTCGTTTTTG
CCGGCCGTTCTACAAATATCTCTTTCTCGAGAAAGAGATATTTGTAGAACGGTTTTTG
CCGGGCAGGTAGTAGAACGGAAGATCTCGAGATCTTCCGTTCTACTACCTGCTTTTTG
CCGGCCATGTAGGCTACAGCATGTACTCGAGTACATGCTGTAGCCTACATGGTTTTTG
CCGGGCCTCACTCTACAGTGCCTCTCTCGAGAGAGGCACTGTAGAGTGAGGCTTTTTG
CCGGGACCTGACACATCCAATTAAACTCGAGTTTAATTGGATGTGTCAGGTCTTTTTG
CCGGCTCCAGTGTCACCCTACAAACCTCGAGGTTTGTAGGGTGACACTGGAGTTTTTG
CCGGGTAGGGCTCCTGTCAACTGTTCTCGAGAACAGTTGACAGGAGCCCTACTTTTTTG
CCGGCAAAGAGATGTGCTCGGCAAACTCGAGTTTGCCGAGCACATCTCTTTGTTTTTG
CCGGCCTGCAGTACATGGAACTCATCTCGAGATGAGTTCCATGTACTGCAGGTTTTTG
CCGGCCGTGCGTACATCGTCACCAACTCGAGTTGGTGACGATGTACGCACGGTTTTTG
CCGGGCCAGACTCTAAAGTGGTGTTCTCGAGAACACCACTTTAGAGTCTGGCTTTTTG
CCGGCGAGGTGGAGTCTGAACTTAACTCGAGTTAAGTTCAGACTCCACCTCGTTTTTG
CCGGATGGCCGTCTCCAGCTAGATACTCGAGTATCTAGCTGGAGACGGCCATTTTTTG
CCGGGCGAGCAGAGACTCAAGGTTTCTCGAGAAACCTTGAGTCTCTGCTCGCTTTTTG
CCGGCCTGAGAGTTTCACCAAGTTTCTCGAGAAACTTGGTGAAACTCTCAGGTTTTTG
CCGGCCTGATATTCAATCTGCACAACTCGAGTTGTGCAGATTGAATATCAGGTTTTTG
CCGGACGACAAACTACATAGCAGAACTCGAGTTCTGCTATGTAGTTTGTCGTTTTTTG
CCGGGCTCGTTTCTGGTCCATACATCTCGAGATGTATGGACCAGAAACGAGCTTTTTG
CCGGGGCACAGATAAGCGCAGAAATCTCGAGATTTCTGCGCTTATCTGTGCCTTTTTG
CCGGGATCTTCTCTTTGGGATATTGCTCGAGCAATATCCCAAAGAGAAGATCTTTTTG
CCGGGCGTACACAATATCGAGGAATCTCGAGATTCCTCGATATTGTGTACGCTTTTTG
CCGGGCTCGACTGTATCCATGACATCTCGAGATGTCATGGATACAGTCGAGCTTTTTG
CCGGGCTGACAGTCAACGCATCTATCTCGAGATAGATGCGTTGACTGTCAGCTTTTT
CCGGCCTTAGCGTAAGCATCTTATACTCGAGTATAAGATGCTTACGCTAAGGTTTTT
CCGGGTGGTGAAAGAGATGAATTATCTCGAGATAATTCATCTCTTTCACCACTTTTTG
CCGGGTGGTGAAAGAGATGAATTATCTCGAGATAATTCATCTCTTTCACCACTTTTTG
CCGGACTACTACGTCGCCGAGTACACTCGAGTGTACTCGGCGACGTAGTAGTTTTTTG
CCGGCCTACTGCAACTCAAGTTAAACTCGAGTTTAACTTGAGTTGCAGTAGGTTTTTG
GCCCGTTATCTGAGCATCATT
AGACCGAATCAATAACAGTTT
GCCAGAAAGATGAAGGGAAAT
CCACCTCTCTTCTGTCTCTTT
TGAAAGTCTAAGCCAACTGAA
CCAGCCAGTGTCAACACGACA
CCTGAAAGGAAGTTCAGATTT
TGGTGTCTACATCCTTAGGCA
CAGAATCGTCGTATGCAGTGA

Hey1
Hey2
Hes1
Hes6
shLuc
TRC, The RNAi Consortium.

(Gibco, Thermo Fisher Scientific), both supplemented with 10% heatinactivated FBS and penicillin-streptomycin. BMSCs were isolated
from tibiae and femurs of 2-month-old mice. Briefly, the bones were
cleanly dissected and the epiphysis cleared off with scissors. Bone
marrow cells were collected from the bones by centrifugation and then
incubated with RBC lysis buffer (MilliporeSigma, R7757-100ML).
The remaining cells were then passed through a 70-μm cell strainer
before being seeded onto a tissue culture plate in α-MEM containing 10% FBS. After daily changes of the medium for 3 days, the cells
were allowed to grow until they reached confluence. The cells were
then dissociated and seeded onto 24-well plates for experiments. For
the Dox-inducible experiments in ST2 cells, the cells were incubated
overnight before treatment with 500 ng/ml Dox (MilliporeSigma,
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D-9891). In some experiments, the cells were infected with dnMaml1or GFP-expressing retroviruses for 8 hours and recovered in regular
media overnight before being seeded overnight for Dox treatment.
The retroviral plasmids MSCV-DNMAML1-GFP and MSCV-GFP
were provided by Jon Aster (Brigham and Women’s Hospital, Boston,
Massachusetts, USA) (41). To test the effect of Jagged1, the cell culture plates were first coated overnight at room temperature with 50
μg/ml protein G (Thermo Fisher Scientific, 10-1201) in Dulbecco’s
phosphate-buffered saline (DPBS) (Life Technologies, Thermo Fisher Scientific). The plates were then washed 3 times with DPBS and
blocked with 10 mg/ml BSA in DPBS for 2 hours at room temperature.
The blocked plates were then washed with DPBS and incubated with
recombinant Jagged1-Fc (R&D Systems, 1277-JG) or CromPure IgG
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Fc (Jackson ImmunoResearch, 009-000-008) at a concentration of
2 μg/ml in 0.1% BSA and PBS for 4 hours at room temperature. After
washing 3 times with DPBS, the cells were immediately seeded onto
the coated plates in the appropriate medium, as described above for
each cell type.
RNA isolation, RT-qPCR, and RNA-Seq. Total RNA was isolated
from NICD2-ST2 cells or BMSCs with the RNeasy Mini Kit (QIAGEN,
74104). Reverse transcription was performed with 400 ng total RNA
and iScript Reverse Transcription Supermix (Bio-Rad, 1708891).
qPCR was performed with an ABI StepOne Plus machine in a 96-well
format using SsoAdvanced Universal CYBR Green Supermix (BioRad, 1725274). Primer sequences are listed in Table 4. 18S rRNA was
used as an internal control, and relative expression was calculated by
the 2–ΔΔCt method.
For RNA-Seq experiments, NICD2-ST2 cells were treated with
vehicle or 500 ng/ml Dox for 24 hours before isolation of total RNA.
Poly-A RNA was isolated from 20 μg total RNA using Oligo-dT beads
[Dynabeads Oligo(dT)25, Thermo Fisher Scientific] and used to generate the PCR-amplified cDNA library, which was then sequenced with
the Illumina HiSeq 2000 as single reads extending 42 bases (Genome
Technology Access Center [GTAC], Washington University School of
Medicine). The raw data were demultiplexed and aligned to the reference genome (mm9) using TopHat. The Partek Genomic Suite was used
to assemble transcripts and analyze their expression. The RNA-Seq data
were deposited in the NCBI’s BioProject database (ID PRJNA488100).
Metabolite measurements. Subconfluent NICD2-ST2 cells growing in αMEM containing 10% FBS were treated with vehicle or 500
ng/ml Dox for 12, 24, or 48 hours. Glucose consumption and lactate
production were measured with the Glucose (HK) Assay Kit (MilliporeSigma, GAHK20) and the L-lactate Assay Kit (Eton biosciences,
1200011002). ATP was measured in cell lysates with the CellTiterGlo Luminescent Cell Viability Assay Kit (Promega, G7573 ). For glucose uptake assays, the cells were incubated with 100 μM 2-NBDG
for 1 hour, and fluorescence intensity was measured according to the
manufacturer’s instructions (Glucose Uptake Cell-Based Assay Kit,
Cayman Chemical, 600470).
Seahorse extracellular flux assays. NICD2-ST2 cells were plated at
5,000 cells/well in XF96 plates coated with Cell-Tak (BD Biosciences). On the next day, the cells were treated with 500 ng/ml Dox for
48 hours with or without inhibitors for the indicated durations before
switching to the assay medium (Seahorse Bioscience, 101022-100,
or MilliporeSigma, D5030-1L) and further incubation in a CO2-free
incubator for 1 hour. Oligomycin (ATP synthase inhibitor), carbonyl
cyanide p-triﬂuoromethoxyphenylhydrazone (FCCP; proton ionophore), antimycin A (complex III inhibitor), and rotenone (complex I
inhibitor) (Seahorse XF Cell Mito Stress Test Kit, Seahorse Bioscience,
1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch
signaling: cell fate control and signal integration in
development. Science. 1999;284(5415):770–776.
2. Chiba S. Notch signaling in stem cell systems.
Stem Cells. 2006;24(11):2437–2447.
3. Schroeter EH, Kisslinger JA, Kopan R. Notch-1
signalling requires ligand-induced proteolytic release of intracellular domain. Nature.
1998;393(6683):382–386.
4. Kopan R, Goate A. A common enzyme connects
notch signaling and Alzheimer’s disease. Genes

103015-100) were prepared in XF assay medium at final concentrations of 5 mM for oligomycin and 1 mM for the rest. At the end of the
assays, protein concentrations were measured for normalization of the
OCR and ECAR.
Measurement of mitochondrial superoxide and mitochondrial complex I activity. For mitochondrial superoxide measurements, NICD2ST2 cells were seeded in 96-well black wall tissue culture plates (Corning, 3904) and treated with vehicle or Dox for 6, 12, or 24 hours. The
cells were then treated with the MitoSOX Red mitochondrial superoxide indicator (Molecular Probes, Thermo Fisher Scientific, M36008)
at 5 μM for 10 minutes at 37°C, washed 3 times with DPBS, and measured at 510/580 nm with a plate reader (BioTek). The fluorescence
intensity was normalized to the DNA content. Mitochondrial complex
I activity was measured with the Complex I Enzyme Activity Microplate Assay Kit (Colorimetric) (Abcam, ab109721).
shRNA knockdown. Lentiviruses expressing shRNA were produced by transfecting HEK293T cells with pLKO.1 shRNA plasmids
(Genome Center at Washington University) and the packaging plasmids pMD2.G and psPAX2 using Fugen6 transfection reagent (Promega). The viral media were added to the cells for 8 hours before being
replaced with fresh growth media for an additional 48 hours. After
treatment with Dox for 24 hours, the cells were harvested for RNA isolation and RT-qPCR. For glucose consumption and lactate production
assays, the cells were harvested 48 hours after Dox treatment. shRNA
targeting sequences are listed in Table 5.
Statistics. Statistical significance was calculated with either a
2-tailed Student’s t test or a 2-way ANOVA. A P value of less than 0.05
was considered significant.
Study approval. The studies in mice were reviewed and approved
by the IACUC of Washington University.
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